BIIB

NASDAQ · Biotechnology

Biogen Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$201.96

+2.37 (+1.19%)

As of Jun 25, 9:37 PM ET ·

Analyst Consensus

Buy

Analysts

Very High

Coverage

Buy 27 61%

Hold 16 36%

Sell 1 2%

Price Target

Analyst Price Target -54.7% upside

Low Target $57.23

Average Target $91.45

High Target $114.90

Current Price $201.96

Current
$201.96

Target
$91.45

$57.23 $91.45 avg $114.90

Scenario Analysis

Bear Case

$57.23

-71.7%

Low target

Base Case

$91.45

-54.7%

Avg target

Bull Case

$114.90

+-43.1%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$205.97

-1.9% from high

52-Week Low

$121.05

+66.8% from low

50-Day SMA

$179.51

+12.5% vs SMA

200-Day SMA

$150.33

+34.3% vs SMA

RSI (14)

64.3

Neutral

Target vs 52W High

$91.45

-55.6% vs high

Next Earnings Report

Jul 16, 2026

19d

until earnings

EPS Est: $3.26

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.9%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+192.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-8.7%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-36.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.2%